Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

TLV:REKA Revenue

Rekah Pharmaceutical Industry had revenue of 72.75M ILS in the quarter ending June 30, 2026, a decrease of -0.16%. This brings the company's total for the last twelve months to 304.04M, down -2.66% year-over-year. In the year 2025, Rekah Pharmaceutical Industry had annual revenue of 300.99M, down -6.44%. That makes Rekah Pharmaceutical Industry the 22,836th largest company in the world by revenue and 254th in Israel.

• Revenue (ttm): 304.04M
• Revenue Growth: -2.66%
• P/S Ratio: 0.39
• Revenue / Employee: 779.58K
• Employees: 390
• Market Cap: 117.11M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Core Products 208.17M 69.2%
• Distribution 75.80M 25.2%
• Extraordinary/Special 17.02M 5.7%

Fiscal year ended Dec 31, 2025 See the full TLV:REKA breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	300.99M	-20.72M	-6.44%
Dec 31, 2024	321.71M	49.00K	0.02%
Dec 31, 2023	321.66M	29.27M	10.01%
Dec 31, 2022	292.39M	28.44M	10.78%
Dec 31, 2021	263.95M	-1.52M	-0.57%

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error